Literature DB >> 16773465

Amino acid challenge in patients with cirrhosis and control subjects: ammonia, plasma amino acid and EEG changes.

Hanan Al Mardini1, Andrew Douglass, Christopher Record.   

Abstract

BACKGROUND/AIMS: The pathogenesis of hepatic encephalopathy (HE) is controversial. We have therefore studied the effect of induced hyperammonaemia in man. PATIENTS AND METHODS: 108 g of an amino acid mixture was given orally to 18 cirrhotics and 11 control subjects and changes in blood ammonia, EEG and plasma amino acids were observed.
RESULTS: Basal (39+/-6 versus 14+/-2 micromol/l) and 120-min post amino acid (77+/-10 versus 27+/-4) blood ammonia concentrations in cirrhotics were significantly increased compared to healthy controls (p < 0.001). Associated with these changes there was a significant increase in the ratio of slow-to-fast wave activity indicating EEG slowing (+0.41+/-0.16; N=13 versus -0.05+/-0.08; N=8; p=0.036). As expected in cirrhotics, basal valine and leucine concentrations were decreased while phenylalanine, tyrosine and methionine were significantly increased. Although the basal molar ratio of branched chain amino acids to the aromatic amino acids phenylalanine and tyrosine was significantly decreased in cirrhotics (1.5+/-0.2 versus 3.2+/-0.2; p < 0.0001), after the challenge when EEG changes were apparent in cirrhotics, the ratio significantly increased (p < 0.005) in both groups to 2.7+/-0.3 versus 4.1+/-0.3 (p=0.002). In the combined groups, there were significant correlations between EEG ratio change and the 120-min blood ammonia concentration (r=0.498; p=0.022).
CONCLUSION: The alterations in plasma amino acid patterns do not support a specific role for any of the amino acid groups in the pathogenesis of hepatic encephalopathy. They are however more in keeping with the direct or indirect role of ammonia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16773465     DOI: 10.1007/s11011-006-9006-5

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  40 in total

1.  Decreased plasma and tissue isoleucine levels after simulated gastrointestinal bleeding by blood gavages in chronic portacaval shunted rats.

Authors:  S W Olde Damink; C H Dejong; N E Deutz; P B Soeters
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

2.  Toxicity and blood ammonia rise resulting from intravenous amino acid administration in man: the protective effect of l-arginine.

Authors:  J L FAHEY
Journal:  J Clin Invest       Date:  1957-12       Impact factor: 14.808

3.  Upper gastrointestinal bleeding: an ammoniagenic and catabolic event due to the total absence of isoleucine in the haemoglobin molecule.

Authors:  S W Olde Damink; C H Dejong; N E Deutz; C L van Berlo; P B Soeters
Journal:  Med Hypotheses       Date:  1999-06       Impact factor: 1.538

Review 4.  Ammonia metabolism in normal and portacaval-shunted rats.

Authors:  A J Cooper
Journal:  Adv Exp Med Biol       Date:  1990       Impact factor: 2.622

Review 5.  Ammonia and GABA-ergic neurotransmission: interrelated factors in the pathogenesis of hepatic encephalopathy.

Authors:  A S Basile; E A Jones
Journal:  Hepatology       Date:  1997-06       Impact factor: 17.425

6.  Brain indoles in human hepatic encephalopathy.

Authors:  H al Mardini; E J Harrison; P G Ince; K Bartlett; C O Record
Journal:  Hepatology       Date:  1993-06       Impact factor: 17.425

7.  Visual attention in cirrhotic patients: a study on covert visual attention orienting.

Authors:  P Amodio; P Marchetti; F Del Piccolo; G Campo; C Rizzo; R M Iemmolo; G Gerunda; L Caregaro; C Merkel; A Gatta
Journal:  Hepatology       Date:  1998-06       Impact factor: 17.425

8.  Subclinical hepatic encephalopathy impairs daily functioning.

Authors:  M Groeneweg; J C Quero; I De Bruijn; I J Hartmann; M L Essink-bot; W C Hop; S W Schalm
Journal:  Hepatology       Date:  1998-07       Impact factor: 17.425

9.  Correlation between ammonia levels and the severity of hepatic encephalopathy.

Authors:  Janus P Ong; Anjana Aggarwal; Derk Krieger; Kirk A Easley; Matthew T Karafa; Frederick Van Lente; Alejandro C Arroliga; Kevin D Mullen
Journal:  Am J Med       Date:  2003-02-15       Impact factor: 4.965

10.  Synaptosomal glutamate transport in thioacetamide-induced hepatic encephalopathy in the rat.

Authors:  K N Oppong; K Bartlett; C O Record; H al Mardini
Journal:  Hepatology       Date:  1995-08       Impact factor: 17.425

View more
  6 in total

Review 1.  Nutritional support for liver disease.

Authors:  Ronald L Koretz; Alison Avenell; Timothy O Lipman
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

2.  Non-invasive urinary metabolomic profiles discriminate biliary atresia from infantile hepatitis syndrome.

Authors:  Wei-Wei Li; Yan Yang; Qi-Gang Dai; Li-Li Lin; Tong Xie; Li-Li He; Jia-Lei Tao; Jin-Jun Shan; Shou-Chuan Wang
Journal:  Metabolomics       Date:  2018-06-21       Impact factor: 4.290

Review 3.  Preoperative optimization for major hepatic resection.

Authors:  Sarah Walcott-Sapp; Kevin G Billingsley
Journal:  Langenbecks Arch Surg       Date:  2017-11-18       Impact factor: 3.445

4.  Predictive value of induced hyperammonaemia and neuropsychiatric profiling in relation to the occurrence of post-TIPS hepatic encephalopathy.

Authors:  Marco Senzolo; Lisa Zarantonello; Chiara Formentin; Costanza Orlando; Raffaello Beltrame; Anna Vuerich; Paolo Angeli; Patrizia Burra; Sara Montagnese
Journal:  Metab Brain Dis       Date:  2019-09-10       Impact factor: 3.584

Review 5.  Pathogenesis of hepatic encephalopathy: lessons from nitrogen challenges in man.

Authors:  Hanan Mardini; Christopher Record
Journal:  Metab Brain Dis       Date:  2012-11-23       Impact factor: 3.584

6.  Influence of Different Antiepileptic Drugs on Blood Ammonia and Homocysteine Levels in Children with Epilepsy.

Authors:  Meng Sun; Ran Zhou; Xin Wang; Yaying Cheng
Journal:  Evid Based Complement Alternat Med       Date:  2021-10-04       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.